Back to News
Market Impact: 0.15
Anavex Life Sciences Corp. Appoints Terrie Kellmeyer, Ph.D. as Chief Executive Officer and President
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as CEO and president effective immediately on November 1, 2026. Kellmeyer, 59, had served as interim CEO since May 4, 2026; the announcement provided no additional performance or strategic details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
AVXL0.20
More News
- ‘Lawyer up’: Democrats take the House, and warn Trump’s family businesses are first in line for subpoenas
- Meta says automation wrongly took down No Kings and a Senate candidate’s page. It’s automating more anyway
- Apple's Happy Holiday Forecast Overshadowed by Shrinking Margin
- Disney plans several thousand layoffs, asks some managers to cut costs by up to 20%
- Midterm elections could jolt stocks if Democrats sweep Congress
- OpenAI’s hiring of former Army Secretary just 2 months after Pentagon resignation is part of a ‘trend’ of it pivoting resources to defense projects